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Abstract Seizures associated with fever are a common
pediatric problem, affecting about 2–7 % of children
between 3 months and 5 years of age. Differentiation of
febrile seizures from acute symptomatic seizures secondary
to central nervous system infections or seizures associated
with fever in children with epilepsy is essential to provide
appropriate treatment and follow-up care. Here, we tested
the hypothesis that children who exhibit simple febrile
seizures during early childhood, but do not develop
epileptic seizures later in life, might preferentially carry the
ApoE2 allele of the gene coding for the apolipoprotein E.
We did not ﬁnd any differences in the distribution of ApoE
alleles or genotypes between individuals who exhibited
simple febrile seizures (n = 93) and age-matched, typi-
cally developing subjects (n = 80). We found that the
observed allele and genotype frequencies did not deviate
from Hardy–Weinberg equilibrium, which suggests that the
frequencies of ApoE alleles and genotypes are stable in the
Swiss population from which our samples were derived.
Across both groups of subjects (n = 173), we found an
ApoE2 allele frequency of 0.064, an ApoE3 frequency of
0.829 and an ApoE4 frequency of 0.107. Our ﬁndings are
consistent with previous reports of the distribution of ApoE
polymorphism for European subjects free of any neuro-
logical disorders, and show that the different alleles of the
gene coding for the apolipoprotein E are not associated
with the occurrence of simple febrile seizures.
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Introduction
Seizures associated with fever are a common pediatric
problem, affecting about 2–7 % of children between
3 months and 5 years of age [1]. Although the vast
majority of children who present with febrile seizures do
not develop epilepsy, the distinction between epilepsy and
febrile seizures is important since the ﬁrst manifestation of
the epilepsy syndrome might occur during a fever episode
at a young age. If a diagnosis of epilepsy has been estab-
lished prior to the episode, appropriate therapeutic mea-
sures are already in place. If not, however, physicians must
wait to see if further seizures develop in order to provide
follow-up care. Adequate diagnosis is, therefore, key to
adequate treatment and patient education that can alleviate
parents’ anxiety and allow the family return to normal life.
To achieve this goal, a number of researchers and practi-
tioners have called for an increased effort to determine the
genetic factors predisposing to febrile seizures and under-
stand the relation between febrile seizures and speciﬁc
epilepsy syndromes [2–8].
The importance of genetic factors in the incidence of
febrile seizures has long been recognized [9, 10], but
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speciﬁc genes that affect febrile seizure cases, and which
are not part of a broader phenotypic spectrum that includes
afebrile seizures, have yet to be conclusively identiﬁed [5,
11]. For example, interleukin 1-beta has been linked to the
generation of febrile seizures [3], but increased frequency
of the interleukin-1-beta-511T allele has also been reported
in patients with temporal lobe epilepsy [12]. Moreover, the
mechanisms by which variants of these particular genes
could contribute speciﬁcally to febrile seizures that are not
associated with epilepsy have yet to be proposed.
Here, we tested the hypothesis that children who exhibit
simple febrile seizures during early childhood, but do not
develop epileptic seizures later in life, might preferentially
carry the ApoE2 allele of apolipoprotein E. This hypothesis
was based on ﬁndings showing that a number of genes
related to astrocytic processes and functions are differen-
tially expressed in the primate hippocampus across post-
natal development [13]. In humans, the highest incidence
of seizures is in the ﬁrst 2 years of life and is most often
associated with a febrile illness [14]. Fever begins with the
activation of immune response cells that produce inter-
leukin-1, which in turn increases prostaglandin E2 syn-
thesis [15]. Prostaglandins act at the level of the
hypothalamus to regulate body temperature and induce
fever. Interestingly, prostaglandins also stimulate calcium-
dependent glutamate release in astrocytes [16, 17], which
can induce abnormal prolonged depolarization with repet-
itive spiking in CA1 pyramidal neurons leading to seizures
[18, 19]. Thus, the relatively high astrocytic coverage of
the dense network of CA1 excitatory synapses in the
newborn [13] might contribute to a higher incidence of
febrile seizures. The decrease in astrocytic coverage of
hippocampal excitatory synapses with development might
in turn reduce the probability of neuronal depolarization
evoked by astrocytic glutamate release, and thus contribute
to the decreased susceptibility to febrile seizures with age.
The pertinent question, then, is why only 2–7 % of children
exhibit febrile seizures [2, 3, 6–8]?
To address this question, we considered the molecular
machinery involved in glutamate uptake and release in
astrocytes. We focused on ApoE as a candidate gene for
three reasons: (1) ApoE is located on chromosome 19q
thought to contain susceptibility genes associated with
febrile seizures, (2) three different genotypes (ApoE2,
ApoE3, ApoE4), linked to single nucleotide polymor-
phisms, have been identiﬁed in humans, and (3)
apolipoprotein E found in the brain is synthesized in
astrocytes and plays a major role in the maintenance of
lipid homeostasis and vesicular trafﬁcking [20, 21]. In
Europeans free of any neurological disorders, the distri-
bution of different alleles is stable, with an ApoE2 fre-
quency of 0.068, an ApoE3 frequency of 0.813 and an
ApoE4 frequency of 0.119 [22]. ApoE2 is more highly
retained in astrocytes than ApoE3 and ApoE4 (Fan and
Fazio, personal communication; see [23] for similar results
in macrophages) and might thus facilitate the pros-
taglandin-induced, calcium-dependent exocytosis of glu-
tamate by astrocytes [16, 17]. In turn, increased glutamate
concentration in the synaptic cleft might induce prolonged
depolarization with repetitive spiking in neurons leading to
seizures. Interestingly, previous studies have considered
the potential link between ApoE and seizures, with some
studies speciﬁcally interested in febrile seizures focusing
their analyses on ApoE4 [24], the allele known to be a risk
factor for Alzheimer’s disease, and other studies consid-
ering all three ApoE alleles included other seizure pheno-
types [25, 26]. However, none of the previous studies was
adequately designed to test the hypothesis that ApoE2
might confer a speciﬁc predisposition to febrile seizures.
Materials and methods
We recruited ninety-three children (45 females, 48 males),
previously diagnosed with a febrile seizure in two hospitals
of the Lemanic Region, Canton of Vaud, Switzerland: the
Hoˆpital du Samaritain, Department of Pediatrics, in Vevey
and the Hoˆpital de l’Enfance, Centre Hospitalier Univer-
sitaire Vaudois, in Lausanne. Selection criteria included a
documented history of simple febrile seizure (FS), the
absence of any other neurological disorders (in particular
other seizure disorders), and the absence of a family history
of neurological or neuropsychiatric disorders. The charac-
teristics of the febrile seizure and the family history of each
patient were evaluated in their personal hospital records,
and again by a senior pediatrician (F.C. or M.G.) during the
encounter with the family. Patients with unclear history
were not enrolled. FS patients experienced a single febrile
seizure episode at an average age of 1.8 years (standard
deviation 1.0 years, median age 1.5 years) and were
enrolled in the study at an average age of 9.5 years (stan-
dard deviation 3.1 years, median age 9.7 years). Eighty
age-matched typically developing (TD) controls (28
females, 52 males) were also recruited at an average age of
9.5 years (standard deviation 2.5 years, median age
9.5 years), via the same recruitment system. The absence
of FS in the patient or his/her family or any other seizure
history was also ascertained by a senior pediatrician, at the
time of saliva sample collection.
FS and TD subjects were asked to provide a saliva
sample to obtain individual samples of genomic DNA.
Saliva was collected with the OG-500 Oragene-DNA self-
collection kit (DNAgenothek, Kanata, ON, Canada), and
returned to our laboratory by the participants via priority
mail. Upon receipt, samples were anonymized and heated
at 50 for 1 h to ensure that DNA was adequately released
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and that nucleases were permanently deactivated, follow-
ing the manufacturer’s protocol (DNAgenothek, Kanata,
ON, Canada). DNA extraction and ApoE analyses were
performed following the protocols provided with the
commercially available ApoE StripAssayTM for the iden-
tiﬁcation of apolipoprotein E isoforms E2, E3 and E4 based
on polymerase chain reaction (PCR) and reverse
hybridization (ViennaLab Labiordiagnostika GmbH,
Vienna, Austria). ApoE has three common alleles (E2, E3,
and E4), differing by the presence of either the C or T
nucleotide at codons 112 and 158 in the fourth exon of the
ApoE gene. ApoE2 contains the sequence TGC coding for
cysteine at both positions, ApoE3 contains the sequence
TGC at codon 112 (coding for cysteine) and the sequence
CGC at codon 158 (coding for arginine), and ApoE4
contains the sequence CGC at both codons, therefore,
coding for arginine at both positions. The six possible
homozygous and heterozygous ApoE genotypes (E2/E2,
E2/E3, E2/E4, E3/E3, E3/E4, E4/E4) result in a combina-
tion of the respective individual isoforms that can easily be
visualized with the ApoE StripAssay. The distribution of
allele frequencies (ApoE2, ApoE3, ApoE4) was calculated
from the observed genotype distributions. Odds ratios were
calculated as (p1 9 (1 - p1))/(p2(1 - p2)), with p1 cor-
responding to the probability of the allele in the population
of subjects with febrile seizures and p2 corresponding to
the probability of the allele in the population of control
subjects. Ninety-ﬁve percent conﬁdence intervals (95 %
CI) of odds ratios were calculated using the following
formula (e(ln (OR) ± sum(1/x)0.5). Chi square statistical
tests were performed to compare the number of individual
genotypes and allele distributions in both populations.
Statistical signiﬁcance was set at p\ 0.05.
This work was approved by the Cantonal Ethics Com-
mission (Vaud) for Human Research (protocol no. 33/10),
and conducted in accordance with the Declaration of Hel-
sinki. The parents of all participants gave informed written
consent.
Results
Alleles distribution
We did not ﬁnd any differences in the distribution of ApoE
alleles between FS and TD subjects (v2 = 1.095, df = 2,
p = 0.5783; Table 1). Across the two groups of subjects
recruited in the Lemanic region of Switzerland, we found
an ApoE2 allele frequency of 0.064, an ApoE3 frequency
of 0.829 and an ApoE4 frequency of 0.107. These ﬁndings
are consistent with previous ﬁndings including 24,262
European subjects free of any neurological disorders, for
which the distribution of the different alleles was rather
stable, with an ApoE2 allele frequency of 0.068, an ApoE3
frequency of 0.813 and an ApoE4 frequency of 0.119
(computed from data compiled by [22]).
Genotypes distribution
We did not ﬁnd any differences in the distribution of ApoE
genotypes between FS and TD subjects (v2 = 4.842,
df = 5, p = 0.4354; Table 2). Across the two groups of
subjects recruited in the Lemanic region of Switzerland, we
found that the most prevalent genotype was E3–E3 with
70.5 % of subjects, followed by E3–E4 with 16.2 % and
E2–E3 with 8.7 %; the other three genotypes (E2–E2, E2–
E4, E4–E4) accounted for less than 5 % of the sampled
population.
Hardy–Weinberg equilibrium
We compared the observed frequencies of ApoE genotypes
(Table 2) with the expected frequencies based on the
Hardy–Weinberg principle
((ApoE2 ? ApoE3 ? ApoE4)2 = 1; Table 3) and found
that the genotype frequencies did not differ from equilib-
rium (FS: v2 = 4.338, df = 5, p = 0.5018; TD:
v2 = 2.461, df = 5, p = 0.7823; total: v2 = 6.035, df = 5,
p = 0.3028). This suggests that the frequencies of ApoE
alleles and genotypes are stable in the Swiss population
from which our samples were derived.
Discussion
We hypothesized that children who exhibit febrile seizures
during early childhood, but do not develop epileptic sei-
zures later in life, might preferentially carry the ApoE2
Table 1 Distribution of ApoE alleles in individuals who exhibited
febrile seizures (FS) and age-matched, typically developing subjects
(TD)
E2 E3 E4
Observed numbers
FS (n = 93) 10 154 22
TD (n = 80) 12 133 15
Total (n = 173) 22 287 37
Chi square p = 0.4347 p = 0.9747 p = 0.4866
Observed frequencies
FS 0.0538 0.8280 0.1183
TD 0.0750 0.8313 0.0938
Total 0.0636 0.8295 0.1069
Odds ratio 0.733 1.015 1.227
95 % CI OR 0.420–1.279 0.582–1.771 0.704–2.141
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allele of apolipoprotein E. In contrast, we did not ﬁnd any
differences in the frequencies of ApoE alleles or genotypes
between FS and TD individuals. We found that the
observed allele and genotype frequencies did not deviate
from Hardy–Weinberg equilibrium. Across both groups
(n = 173 subjects), we found an ApoE2 allele frequency of
0.064, an ApoE3 frequency of 0.829 and an ApoE4 fre-
quency of 0.107. Our ﬁndings are thus consistent with
previous reports for European subjects free of any neuro-
logical disorders, in particular with previous results for a
population of 173 subjects derived from the same Lemanic
region of Switzerland (Geneva; [27]): ApoE2 allele fre-
quency of 0.072, ApoE3 frequency of 0.821 and ApoE4
frequency of 0.107. Our ﬁndings indicate that the different
alleles of the ApoE gene coding for the apolipoprotein E
are not associated with a predisposition to exhibit febrile
seizures during early childhood. One possible caveat of our
study is the fact that we analyzed fewer than 100 subjects
per group. However, in order to be clinically relevant, any
association between one gene’s polymorphism and a
medical condition should be signiﬁcant even with such a
small number of individuals. If larger numbers of subjects
are required to demonstrate a statistically signiﬁcant asso-
ciation, such information is unlikely to be useful for
everyday practice.
A previous study by Giray et al. [24] also failed to ﬁnd
differences in allele and genotype frequencies between 69
patients with febrile convulsions and 75 control subjects
derived from the Turkish population. However, the distri-
bution of ApoE alleles in their control group differed from
what was previously reported by Corbo et al. [27] based on
the genotyping of 8453 individuals (v2 = 21.97, df = 2,
p\ 0.0001). The frequency of the ApoE2 allele in their
control population also differed from that observed in our
control population (v2 = 4.21, df = 1, p = 0.0401), rais-
ing some questions regarding the reliability of their sam-
pling or their sequencing methods. The attempt by Giray
et al. [24] to further deﬁne different genetic predispositions
between simple and complex febrile seizures is also difﬁ-
cult to justify given the small number of subjects with
complex seizures comprised in their study (n = 17). Other
studies have failed to ﬁnd a causal relationship between
ApoE polymorphism and epilepsy: Blumcke et al. [25]
failed to demonstrate an association between ApoE poly-
morphism and early onset temporal lobe epilepsy; Yeni
et al. failed to demonstrate an association between ApoE
polymorphism and mesial temporal lobe epilepsy with
hippocampal sclerosis; Fu et al. [28] reported that ApoE4
does not increase the risk for temporal lobe epilepsy in the
Chinese Han population, in the absence of prior trauma. In
contrast, Kauffman et al. [29] reported that the ApoE4
allele might be associated with an earlier onset of temporal
lobe epilepsy. Thus, in contrast to the well-established
association between ApoE polymorphism and the risk of
developing Alzheimer’s disease [30], there does not seem
to be a simple, direct association between ApoE
Table 2 Distribution of ApoE
genotypes in individuals who
exhibited febrile seizures (FS)
and age-matched, typically
developing subjects (TD)
E2–E2 E2–E3 E2–E4 E3–E3 E3–E4 E4–E4
FS (n = 93) 0 7 3 66 15 2
TD (n = 80) 1 8 2 56 13 0
Total (n = 173) 1 15 5 122 28 2
Chi square p = 0.3346 p = 0.7074 p = 0.6449 p = 0.2362 p = 0.5967 p = 0.1713
Frequencies
FS 0.0000 0.0753 0.0323 0.7097 0.1613 0.0215
TD 0.0125 0.1000 0.0250 0.7000 0.1625 0.0000
Total 0.0058 0.0867 0.0289 0.7052 0.1618 0.0116
Table 3 Predicted distribution
of ApoE genotypes in
individuals who exhibited
febrile seizures (FS) and age-
matched, typically developing
subjects (TD), following the
Hardy–Weinberg equation for
equilibrium
E2–E2 E2–E3 E2–E4 E3–E3 E3–E4 E4–E4
Numbers
FS (n = 93) 0 8 1 63 18 1
TD (n = 80) 0 10 1 56 13 1
Total (n = 173) 1 17 2 108 28 2
Frequencies
FS 0.0029 0.0890 0.0127 0.6855 0.1959 0.0140
TD 0.0056 0.1247 0.0141 0.6910 0.1559 0.0088
Total 0.0040 0.1055 0.0136 0.6880 0.1774 0.0114
The genotype frequencies of ApoE were in Hardy–Weinberg equilibrium for both groups
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polymorphism and the susceptibility to exhibit seizures of
various etiologies.
In sum, although our hypothesis that ApoE2 might
confer a predisposition to simple febrile seizures was not
validated, it remains possible that the cellular pathways
involved in the regulation of glutamate uptake and release
by astrocytes are associated with the susceptibility to
exhibit febrile seizures early in life. Since hundreds of
genes have the potential to inﬂuence these cellular path-
ways, this hypothesis could be further tested with a gen-
ome-wide approach to identify possible genetic markers of
febrile seizures. Using this approach, recent studies found
that variants of the sodium channel gene SCN1A are
associated with general and MMR vaccine-related febrile
seizures [4], but also with mesial temporal lobe epilepsy
with hippocampal sclerosis, with and without a history of
febrile seizures [5]. If such markers can be found, the
development and use of cost-effective sequencing tech-
nologies available to clinicians should be combined with
the development and use of functional analysis tools that
can comprehend multiple gene pathways for routine diag-
nostic. Altogether, such methods might help to better dis-
tinguish a benign childhood disorder with an excellent
prognosis from other seizure phenotypes associated with an
increased risk of developing epilepsy later in life.
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